Joel Ackerman Champions Oncology, Inc. (CSBR) insider trading activity

CSBR Quotes by TradingView

Joel Ackerman is Director of CHAMPIONS ONCOLOGY, INC.. Currently has a direct ownership of 1.06 Million shares of CSBR, which is worth approximately $7.13 Million. The most recent transaction as insider was on Oct 30, 2025, when has been sold 94,405 shares (Common Stock) at a price of $2.1 per share, resulting in proceeds of $198,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.06M
9.81% 3M change
9.81% 12M change
Total Value Held $7.13 Million

JOEL ACKERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 30 2025
BUY
Exercise of conversion of derivative security
$198,250 $2.1 p/Share
94,405 Added 8.2%
1,056,539 Common Stock
Oct 31 2024
BUY
Exercise of conversion of derivative security
$396,366 $3.77 p/Share
105,137 Added 9.85%
962,134 Common Stock
Oct 17 2023
BUY
Exercise of conversion of derivative security
$240,559 $2.1 p/Share
114,552 Added 11.79%
856,997 Common Stock
Oct 19 2022
BUY
Exercise of conversion of derivative security
$53,501 $3.21 p/Share
16,667 Added 1.13%
1,460,595 Common Stock
Mar 03 2020
BUY
Exercise of conversion of derivative security
$670,243 $5.28 p/Share
126,940 Added 8.08%
1,443,928 Common Stock

Also insider at

DVA
DAVITA INC. Healthcare
CFO and Treasuer
JA

Joel Ackerman

Director
Denver, CO

Track Institutional and Insider Activities on CSBR

Follow CHAMPIONS ONCOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSBR shares.

Notify only if

Insider Trading

Get notified when an Champions Oncology, Inc. insider buys or sells CSBR shares.

Notify only if

News

Receive news related to CHAMPIONS ONCOLOGY, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CSBR